Keenova Therapeutics plc EBITDA
Keenova Therapeutics plc EBITDA
- 2026-06-30: Basis Reported; EBITDA (m); Operating income -$203.10M; Depreciation and amortization (m).
- 2026-03-31: Basis Reported; EBITDA -$6.00M*; Operating income -$67.00M; Depreciation and amortization $61.00M.
- 2025-09-26: Basis Reported; EBITDA (m); Operating income -$269.10M; Depreciation and amortization (m).
- 2025-06-27: Basis Reported; EBITDA (m); Operating income -$7.10M; Depreciation and amortization (m).
Historical EBITDA
EBITDA 3 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|
| 2026-06-30 | Reported | (m) | -$203.10M | (m) | (m) | (m) | (m) | (m) | $235.20M | $25.00M | $243.80M | -$23.00M |
|---|
| 2026-03-31 | Reported | -$6.00M* | -$67.00M | $61.00M | (m) | (m) | $10.40M | (m) | $281.70M | $23.20M | $210.60M | $4.80M |
|---|
| 2025-09-26 | Reported | (m) | -$269.10M | (m) | (m) | (m) | (m) | (m) | $499.10M | $44.30M | $351.70M | -$35.90M |
|---|
| 2025-06-27 | Reported | (m) | -$7.10M | (m) | (m) | (m) | (m) | (m) | $113.60M | $18.00M | $116.40M | $2.00M |
|---|
| 2025-03-28 | Reported | -$24.20M* | -$36.60M | $12.40M | (m) | (m) | $10.60M | $66.30M | $95.10M | $15.30M | $114.90M | -$1.70M |
|---|
| 2024-09-27 | Reported | (m) | $36.40M | (m) | (m) | (m) | (m) | (m) | $284.40M | $28.20M | $141.20M | $7.20M |
|---|
| 2024-06-28 | Reported | (m) | $27.40M | (m) | (m) | (m) | (m) | (m) | $319.30M | $29.20M | $127.90M | $13.90M |
|---|
| 2024-03-29 | Reported | $17.40M* | -$17.70M | $35.10M | (m) | (m) | $24.60M | $15.80M | $303.80M | $27.90M | $136.90M | -$700.00K |
|---|
| 2023-09-29 | Reported | (m) | -$282.00M | (m) | (m) | (m) | (m) | (m) | $346.20M | $25.70M | $129.20M | $10.80M |
|---|
| 2023-06-30 | Reported | (m) | -$56.60M | (m) | (m) | (m) | (m) | (m) | $370.10M | $29.00M | $122.40M | $528.10M |
|---|
| 2023-03-31 | Reported | $42.50M* | -$102.60M | $145.10M | (m) | (m) | $19.30M | $99.90M | $374.80M | $28.30M | $118.00M | -$30.80M |
|---|
| 2022-09-30 | Reported | -$2.10M* | -$199.00M | $196.90M | (m) | (m) | $15.60M | $19.30M | $552.10M | $34.50M | $143.40M | -$34.60M |
|---|
| 2022-09-30 | Reported | (m) | -$144.20M | (m) | (m) | (m) | (m) | (m) | $449.90M | $28.30M | $122.30M | -$24.90M |
|---|
| 2022-06-16 | Reported | (m) | -$37.00M | (m) | (m) | (m) | (m) | (m) | $266.80M | $28.30M | $122.80M | -$491.40M |
|---|
| 2022-04-01 | Reported | $156.40M* | -$20.80M | $177.20M | (m) | (m) | $23.60M | $49.20M | $315.20M | $37.20M | $152.50M | -$5.90M |
|---|
| 2021-09-24 | Reported | (m) | -$122.60M | (m) | (m) | (m) | (m) | (m) | $319.20M | $47.30M | $127.30M | -$32.00M |
|---|
| 2021-06-25 | Reported | (m) | $10.90M | (m) | (m) | (m) | (m) | (m) | $331.60M | $52.80M | $145.00M | -$33.50M |
|---|
| 2021-03-26 | Reported | $152.10M* | -$17.50M | $169.60M | (m) | (m) | $20.90M | $151.40M | $307.60M | $66.20M | $136.00M | -$16.40M |
|---|
| 2020-09-25 | Reported | (m) | $41.50M | (m) | (m) | (m) | (m) | (m) | $403.00M | $65.50M | $220.80M | -$211.60M |
|---|
| 2020-06-26 | Reported | (m) | -$725.50M | (m) | (m) | (m) | (m) | (m) | $386.70M | $82.90M | $231.30M | $161.30M |
|---|
| 2020-03-27 | Reported | $216.80M* | -$6.30M | $223.10M | (m) | (m) | $19.90M | $53.70M | $382.00M | $77.40M | $231.10M | -$18.90M |
|---|
| 2019-09-27 | Reported | (m) | $8.30M | (m) | (m) | (m) | (m) | (m) | $419.40M | $103.10M | $205.70M | -$27.60M |
|---|
| 2019-06-28 | Reported | (m) | -$29.90M | (m) | (m) | (m) | (m) | (m) | $434.40M | $79.60M | $225.90M | -$24.30M |
|---|
| 2019-03-29 | Reported | $263.00M* | $15.40M | $247.60M | (m) | (m) | $39.80M | $164.50M | $455.50M | $85.30M | $230.20M | -$204.70M |
|---|
| 2018-09-28 | Reported | (m) | $69.50M | (m) | (m) | (m) | (m) | (m) | $433.50M | $86.10M | $193.40M | -$122.90M |
|---|
| 2018-06-29 | Reported | (m) | $52.70M | (m) | (m) | (m) | (m) | (m) | $431.50M | $92.60M | $189.90M | -$44.40M |
|---|
| 2018-03-30 | Reported | $224.70M* | $26.10M | $198.60M | (m) | (m) | $34.30M | (m) | $407.80M | $82.00M | $211.20M | -$36.60M |
|---|
| 2017-09-29 | Reported | (m) | $83.60M | (m) | (m) | (m) | (m) | (m) | $268.00M | $46.90M | $186.30M | -$57.80M |
|---|
| 2017-06-30 | Reported | (m) | $50.10M | (m) | (m) | (m) | (m) | (m) | (m) | $52.30M | $214.60M | -$53.60M |
|---|
| 2017-03-31 | Reported | $290.30M* | $86.30M | $204.00M | (m) | (m) | $52.60M | (m) | (m) | $45.00M | $217.60M | -$42.00M |
|---|
| 2016-12-30 | Reported | $44.60M* | -$158.60M | $203.20M | (m) | (m) | $65.20M | (m) | $383.20M | $66.10M | $321.10M | -$121.70M |
|---|
| 2016-09-30 | Reported | (m) | $147.70M | (m) | (m) | (m) | (m) | (m) | (m) | $67.90M | $267.80M | -$56.40M |
|---|
| 2016-06-24 | Reported | (m) | $175.10M | (m) | (m) | (m) | (m) | (m) | (m) | $74.80M | $224.90M | -$98.10M |
|---|
| 2016-03-25 | Reported | $343.90M* | $132.40M | $211.50M | (m) | (m) | $42.40M | (m) | (m) | $58.10M | $209.30M | -$63.80M |
|---|
| 2015-12-25 | Reported | $42.00M* | -$164.00M | $206.00M | (m) | (m) | $49.00M | (m) | $360.00M | $61.30M | $221.80M | -$37.30M |
|---|
| 2015-06-26 | Reported | (m) | $127.10M | (m) | (m) | (m) | (m) | (m) | (m) | $59.90M | $295.00M | -$1.20M |
|---|
| 2015-03-27 | Reported | (m) | $93.90M | (m) | (m) | (m) | (m) | (m) | (m) | $58.00M | $308.40M | -$34.10M |
|---|
| 2014-12-26 | Reported | $272.20M* | $121.60M | $150.60M | (m) | (m) | $22.30M | (m) | (m) | $52.70M | $224.10M | -$10.30M |
|---|
| 2014-06-27 | Reported | (m) | -$4.40M | (m) | (m) | (m) | (m) | (m) | (m) | $42.70M | $221.30M | -$2.40M |
|---|
| 2014-03-28 | Reported | (m) | $3.70M | (m) | (m) | (m) | (m) | (m) | (m) | $41.40M | $194.10M | -$20.30M |
|---|
| 2013-12-27 | Reported | $108.20M* | $73.10M | $35.10M | (m) | (m) | $21.70M | (m) | (m) | $39.00M | $146.20M | $16.60M |
|---|
| 2013-06-28 | Reported | (m) | -$600.00K | (m) | (m) | (m) | (m) | (m) | (m) | $44.80M | $166.90M | $19.80M |
|---|
| 2013-03-29 | Reported | (m) | $53.50M | (m) | (m) | (m) | (m) | (m) | (m) | $39.20M | $160.70M | $19.00M |
|---|
| 2012-12-28 | Reported | $70.50M* | $36.80M | $33.70M | (m) | (m) | $42.80M | (m) | (m) | $38.40M | $146.80M | $17.10M |
|---|
| 2012-06-29 | Reported | (m) | $59.40M | (m) | (m) | (m) | (m) | (m) | (m) | $35.20M | $137.20M | $24.40M |
|---|
EBITDA 12 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|
| 2025-12-31 | Reported | -$217.70M* | -$348.20M | $130.50M | (m) | (m) | $50.40M | (m) | $787.80M | $90.70M | $761.30M | -$23.80M |
|---|
| 2024-12-27 | Reported | $7.70M* | -$65.90M | $73.60M | (m) | (m) | $54.80M | $160.70M | $544.10M | $89.30M | $461.50M | $113.30M |
|---|
| 2021-12-31 | Reported | $472.90M* | -$202.90M | $675.80M | (m) | (m) | $55.30M | $455.40M | $1.32B | $205.20M | $581.40M | -$106.30M |
|---|
| 2020-12-25 | Reported | $233.60M* | -$651.60M | $885.20M | (m) | (m) | $47.70M | $498.90M | $1.54B | $290.80M | $884.10M | $8.90M |
|---|
| 2019-12-27 | Reported | -$871.10M* | -$1.82B | $951.10M | (m) | (m) | $133.00M | $742.90M | $1.74B | $349.40M | $831.00M | -$584.30M |
|---|
| 2018-12-28 | Reported | -$2.87B* | -$3.72B | $852.10M | (m) | (m) | $127.00M | $665.50M | $1.74B | $361.10M | $834.10M | -$430.10M |
|---|
| 2017-12-29 | Reported | $1.30B* | $492.90M | $808.30M | (m) | (m) | $186.10M | $727.30M | $1.56B | $276.90M | $849.70M | -$1.71B |
|---|
| 2017-09-29 | Rolling | (m) | $61.40M* | (m) | (m) | (m) | (m) | (m) | (m) | $210.30M* | $939.60M* | -$275.10M* |
|---|
| 2017-06-30 | Rolling | (m) | $125.50M* | (m) | (m) | (m) | (m) | (m) | (m) | $231.30M* | $1.02B* | -$273.70M* |
|---|
| 2017-03-31 | Rolling | (m) | $250.50M* | (m) | (m) | (m) | (m) | (m) | (m) | $253.80M* | $1.03B* | -$318.20M* |
|---|
| 2016-12-30 | Rolling | (m) | $296.60M* | (m) | (m) | (m) | (m) | (m) | (m) | $266.90M* | $1.02B* | -$340.00M* |
|---|
| 2016-09-30 | Reported | $1.47B* | $633.10M | $834.50M | (m) | (m) | $182.90M | (m) | $1.52B | $261.20M | $913.70M | -$255.60M |
|---|
| 2016-09-30 | Rolling | (m) | $291.20M* | (m) | (m) | (m) | (m) | (m) | (m) | $262.10M* | $923.80M* | -$255.60M* |
|---|
| 2015-09-25 | Reported | $1.03B* | $353.80M | $672.50M | (m) | (m) | $148.00M | (m) | (m) | $203.30M | $1.02B | -$129.30M |
|---|
| 2014-09-26 | Reported | $319.30M* | $43.40M | $275.90M | (m) | (m) | $127.80M | (m) | (m) | $140.50M | $611.00M | -$12.60M |
|---|
| 2013-09-27 | Reported | $213.10M* | $73.50M | $139.60M | (m) | (m) | $147.90M | (m) | (m) | $157.90M | $495.90M | $47.50M |
|---|
| 2012-09-28 | Reported | $366.10M* | $235.20M | $130.90M | (m) | (m) | $144.20M | (m) | (m) | $144.10M | $551.70M | $94.80M |
|---|
| 2011-09-30 | Reported | $360.50M* | $240.70M | $119.80M | (m) | (m) | $120.40M | (m) | (m) | $141.50M | $532.50M | $86.20M |
|---|